TY  - JOUR
AU  - Fiorini, Claudia 
AU  - Cordani, Marco
AU  - Padroni, Chiara 
AU  - Blandino, Giovanni 
AU  - Di Agostino, Silvia 
AU  - Donadelli, Massimo 
PY  - 2015
DO  - 10.1016/j.bbamcr.2014.10.003
SN  - 0167-4889
UR  - https://hdl.handle.net/20.500.14352/94640
T2  - Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
AB  - Pancreatic adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths worldwide; PDAC is characterized by poor prognosis, resistance to conventional chemotherapy and high mortality rate. TP53 tumor suppressor gene is frequently mutated...
LA  - eng
M2  - 89
PB  - Elsevier
KW  - Pancreatic adenocarcinoma
KW  - Gemcitabine
KW  - Mutant p53
KW  - Gain-of-function (GOF)
KW  - Autophagy
KW  - p53-reactivating molecules
TI  - Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine
TY  - journal article
VL  - 1853
ER  -